Which ETFs hold Moderna Inc (MRNA)?
American biotech company developing mRNA vaccines and medicines, including COVID-19 vaccines.
30 Australian ETFs hold Moderna Inc, a Health Care company from United States. CURE has the biggest weighting at 2.36%. Across these funds, Australian ETF investors own about $121m of Moderna Inc.
The ETFs with the most Moderna Inc
All 30 ETFs that hold Moderna Inc, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Moderna Inc.
Common questions
Which ETF has the most Moderna Inc?
CURE (Global X S&P Biotech ETF) has the highest weighting, with 2.36% of the fund in Moderna Inc.
What is the cheapest ETF that holds Moderna Inc?
Of the ETFs where Moderna Inc is at least 1% of the fund, CURE has the lowest fee at 0.45% a year, with 2.36% in Moderna Inc.
How much Moderna Inc do I own with $10,000 in IVV?
About $13. IVV is the largest ETF that holds Moderna Inc, and Moderna Inc makes up 0.13% of it.
How many Australian ETFs hold Moderna Inc?
30 ETFs listed on the ASX or TMX Australia hold Moderna Inc, based on issuers' published holdings.